Nicolas Hubacz: Mesenchymal Stem Cells Are Some of the Most Fascinating Cells in Regenerative Medicine
Nicolas Hubacz, Research and Clinical Products Business Development Manager at Magstim, shared a post on LinkedIn:
“The Body’s Cellular Repair Crew, Mesenchymal stem cells (MSCs) are some of the most fascinating cells in regenerative medicine.
Found in bone marrow, fat tissue, umbilical cord tissue, and other organs, these cells can both transform into specialized cell types and influence healing through powerful signaling mechanisms.
What makes MSCs especially interesting is that their therapeutic potential may come less from ‘becoming new tissue’ and more from how they communicate with the immune system and damaged cells around them.
What MSCs can do:
- Modulate inflammation and immune responses
- Support tissue repair and wound healing
- Differentiate into bone, cartilage, muscle, and fat cells
- Release growth factors and extracellular vesicles that influence surrounding cells
- Serve as a major focus of regenerative medicine and bioengineering research
Researchers are actively studying MSCs in areas ranging from neurodegenerative disease and stroke recovery to orthopedic injury, autoimmune disorders, and cardiovascular disease.
The video of MSCs in motion is a reminder that biology is incredibly dynamic at the microscopic scale. These aren’t static structures — they constantly migrate, interact, signal, and adapt to their environment.
One of the most exciting shifts in recent years has been the growing understanding that stem cell therapies may work through entire cellular ecosystems, not just through cell replacement alone.
Credit to Nanolive SA for the great video!”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Jun 26, 2026, 18:28Daniel Pereira Monteiro: Why Is Beta Thalassaemia Major so Severe?
-
Jun 26, 2026, 18:27Pradip Pawar: Cell and Gene Therapy – Transforming Medicine in the 21st Century
-
Jun 26, 2026, 18:26Aviva Schwartz: How Can We Better Protect Patients After an Ischemic Stroke?
-
Jun 26, 2026, 18:25Does Reversing Factor Xa Inhibitors Really Carry as Much Thrombotic Risk as We Think? – RPTH Journal
-
Jun 26, 2026, 18:25Akshat Jain: Novel Therapies in Childhood Blood and Cancer Disorders
-
Jun 26, 2026, 16:57Abdul Muqtadir Abbasi: Anticoagulation in DVT Patients With Hidden Varices Requires Extreme Caution
-
Jun 26, 2026, 16:42Anesa Mulabecirovic: Why Von Willebrand Disease Takes Years to Diagnose in Women
-
Jun 26, 2026, 16:32Kaitlin Lichty: A New Identity Reflecting a Shared Legacy of Bleeding Disorders
-
Jun 26, 2026, 16:07Toong Youttananukorn: The WFH Registry Driving Better Care and Advocacy